Growing investments in mRNA vaccine and therapeutic platforms, along with regulatory acceleration, are fueling steady global demand for high-purity raw materials.Austin, Nov. 04, 2025 (GLOBE NEWSWIRE) ...
Inside the Booming mRNA Therapeutics MarketThe mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most ...
Arcturus Therapeutics Holdings Inc. faces a solid cash runway into 2028, pipeline setbacks, and risk/reward profile. Learn ...
Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug on ...
6don MSN
Customizable nanomedicine platform shows promise for advancing personalized mRNA cancer therapeutics
Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent off-target effects and treatment-resistant tumor microenvironments have ...
Researchers at Harvard Medical School and Brigham and Women's Hospital designed an ingestible capsule that delivers liquid mRNA to the intestines, producing gene expression and reducing inflammation ...
The United States may be losing its edge in mRNA technology. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...
Scientists in NSW have developed a potential world-first mRNA vaccine to protect cattle from foot and mouth disease. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback